default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

Ildong signs co-promotion contract with GSK Consumer Healthcare

Lee Han-soo  Published 2019.12.03  15:18  Updated 2019.12.03 15:18

공유
default_news_ad2

Ildong pharmaceutical said that it will co-promote GSK Consumer Healthcare’s over-the-counter and other consumer health-related products.

The products include Theraflu, Otrivin, Nicotin-L, Driclor, Voltaren, Polident, Sensodyne, Parodontax, and Breathe Right. Sales of these products amounted to about 46 billion won ($38.7 million) last year.

“This is the largest single co-promotion contract in the domestic OTC and consumer healthcare sectors,” the company said. “As the products did well last year, Ildong estimates that it will be able to achieve 50 billion won in annual sales.”

As a result of this agreement, Ildong will also be able to achieve annual sales of more than 200 billion won in OTC business alone from next year, the company added.

The company plans to increase sales and profitability through efficient distribution and inventory management, which are strengths of its online drug store, Ildong Shop, it went on to say.

“Following the co-promotion agreement with GSK Korea for Relenza, a cold medicine, the company was able to expand its partnership with GSK Consumer Healthcare in the field of OTC and consumer healthcare,” a company official said. We will work with GSK to create results and satisfy customers while continuing to seek partnerships that will help us to grow together.”

corea022@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch